LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,895 | -45.9% | 7,244 | +13.8% | 0.00% | – |
| Q2 2023 | $14,581 | +108.3% | 6,368 | +121.0% | 0.00% | – |
| Q1 2023 | $7,001 | +16.7% | 2,882 | -12.0% | 0.00% | – |
| Q4 2022 | $6,000 | -25.0% | 3,274 | -9.4% | 0.00% | – |
| Q3 2022 | $8,000 | +100.0% | 3,614 | +39.5% | 0.00% | – |
| Q2 2022 | $4,000 | 0.0% | 2,591 | +4.4% | 0.00% | – |
| Q1 2022 | $4,000 | -60.0% | 2,482 | -3.0% | 0.00% | – |
| Q4 2021 | $10,000 | +42.9% | 2,559 | +67.9% | 0.00% | – |
| Q3 2021 | $7,000 | +16.7% | 1,524 | +15.1% | 0.00% | – |
| Q2 2021 | $6,000 | -40.0% | 1,324 | -21.6% | 0.00% | – |
| Q1 2021 | $10,000 | +100.0% | 1,689 | -5.6% | 0.00% | – |
| Q4 2020 | $5,000 | +400.0% | 1,790 | +56.5% | 0.00% | – |
| Q3 2020 | $1,000 | -80.0% | 1,144 | -56.3% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 2,620 | +16.7% | 0.00% | – |
| Q1 2020 | $4,000 | – | 2,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
| Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
| MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
| Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
| FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
| WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
| HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |